These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33037667)

  • 1. Survival trends in elderly myeloma patients.
    Jones A; Bowcock S; Rachet B
    Eur J Haematol; 2021 Jan; 106(1):126-131. PubMed ID: 33037667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age disparities in survival from lymphoma and myeloma: a comparison between US and England.
    Pulte D; Redaniel MT; Lowry L; Bird J; Jeffreys M
    Br J Haematol; 2014 Jun; 165(6):824-31. PubMed ID: 24684252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
    Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
    BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma.
    Winn AN; Shah GL; Cohen JT; Lin PJ; Parsons SK
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26023094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
    Mian HS; Wildes TM; Fiala MA
    JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
    Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
    Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
    Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
    Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the incidence and survival of multiple myeloma in South East England 1985-2004.
    Renshaw C; Ketley N; Møller H; Davies EA
    BMC Cancer; 2010 Mar; 10():74. PubMed ID: 20193064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.
    Pulte D; Gondos A; Brenner H
    Oncologist; 2011; 16(11):1600-3. PubMed ID: 21968047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
    Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
    Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.
    Libby E; Garcia D; Quintana D; Fekrazad MH; Bauman J; Ebaid A; Hromas R; Rabinowitz I; Wiggins C
    Leuk Lymphoma; 2014 Dec; 55(12):2850-7. PubMed ID: 24588734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma: unplanned diagnostic pathways and association with risk factors and survival - a nationwide register-based cohort study in Denmark.
    Rasmussen LA; Vedsted P; Jensen H; Frederiksen H; El-Galaly TC; Kristensen IB; Virgilsen LF
    BMC Cancer; 2024 Aug; 24(1):998. PubMed ID: 39134966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
    Fiala MA; Finney JD; Liu J; Stockerl-Goldstein KE; Tomasson MH; Vij R; Wildes TM
    Leuk Lymphoma; 2015; 56(9):2643-9. PubMed ID: 25651424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes Associated With Chronic Kidney Disease in Elderly Medicare Patients With Multiple Myeloma.
    Li S; Gong T; Kou C; Fu A; Bolanos R; Liu J
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):401-412.e24. PubMed ID: 33658169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities in multiple myeloma and implications on survival: A population-based study.
    Sverrisdóttir IS; Rögnvaldsson S; Thorsteinsdottir S; Gíslason GK; Aspelund T; Turesson I; Björkholm M; Gregersen H; Hveding Blimark C; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Jun; 106(6):774-782. PubMed ID: 33565126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.
    Gavriatopoulou M; Fotiou D; Koloventzou U; Roussou M; Migkou M; Ntanasis-Stathopoulos I; Kanellias N; Ziogas DC; Panagiotidis I; Gika D; Eleutherakis-Papaiakovou E; Terpos E; Kastritis E; Dimopoulos MA
    Leuk Lymphoma; 2019 Mar; 60(3):619-628. PubMed ID: 30628505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing survival of people with myeloma and end stage kidney disease: A cohort study using Australian and New Zealand dialysis and transplant registry 1963-2013.
    Webster AC; Irish AB; Kelly PJ
    Nephrology (Carlton); 2018 Mar; 23(3):217-225. PubMed ID: 28004444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.